Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.31 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6179357 | 0.87 | — | — | |
| SCHEMBL5426252 | 0.82 | TDP1 (0.36) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL9626812 | 0.74 | TSHR (0.39) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL6178981 | 0.74 | TSHR (0.39) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL4983569 | 0.72 | TSHR (0.46) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL19845102 | 0.72 | TSHR (0.46) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL4492563 | 0.72 | TSHR (0.46) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL27862153 | 0.71 | TSHR (0.37) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL16122257 | 0.70 | TSHR (0.39) | TSHRCES1CYP3A4SMN1; SMN2HPGD | |
| SCHEMBL28930056 | 0.70 | CES1 (0.52) | TSHRCES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |